Sep 2023 – Our New Study: The Burden of Patent Thickets
I-MAK’s Quest To Trim The Biopharmaceutical Patent Thicket
![](https://www.i-mak.org/wp-content/uploads/2023/03/26nextpandemic-newsletter-image-jumbo.jpeg)
The Next Pandemic with Priti Krishtel and Tahir Amin
Big Pharma fights patent disclosure demand from investors
![](https://www.i-mak.org/wp-content/uploads/2023/02/Stop-Big-Pharma-Drug-Prices.webp)
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
Patent reform and lower drug prices should be bipartisan priorities
![](https://www.i-mak.org/wp-content/uploads/2023/01/00Humira-01-qblc-superJumbo-Copy.png)
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
How AbbVie denied Americans access to fair competition for Humira
![](https://www.i-mak.org/wp-content/uploads/2022/11/634dd5ba6bd5270019150ac1.webp)
Life-Changing Drug Costs Over $3,000 in US, $0 to $225 in Europe
![](https://www.i-mak.org/wp-content/uploads/2022/09/money_patent_drugs_large.jpeg)
Report pulls no punches in critique of drug patent abuse